Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New sections for Study Status and Study Identification were added to the study history on 2026-07-10 and 2026-07-08, representing updates to the trial’s current status and identifying details; a deletion was recorded on 2026-06-29.
    Difference
    0.4%
    Check dated 2026-07-10T22:52:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    This update adds several core study sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Sponsor/Collaborators, Study Status) and introduces Revision: v3.6.3 (version 14) to the record, reflecting expanded study detail.
    Difference
    1.0%
    Check dated 2026-07-03T20:09:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag (v3.6.2), replacing the previous v3.6.0, indicating the study record has been updated.
    Difference
    0.1%
    Check dated 2026-06-26T23:48:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The newer version deletes several core study-record sections (Contacts/Locations, Study Status, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Oversight, Study Identification, Recruitment Status) that together define how the trial is conducted and presented.
    Difference
    11%
    Check dated 2026-06-19T23:01:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page adds quick-access links 'Check who can join' and 'Find Contact Information' and updates the revision label from v3.5.5 to v3.6.0, representing a small UI/branding update in the study history.
    Difference
    0.4%
    Check dated 2026-06-12T16:35:39.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4 in the record history, marking a new platform release. It does not alter trial data or study details.
    Difference
    0.1%
    Check dated 2026-06-05T11:47:22.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.